These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18797341)

  • 1. Surrogate measures of outcome in clinical trials: clues worth examining?
    Carter BS; Awad IA
    Neurosurgery; 2008 Aug; 63(2):N5. PubMed ID: 18797341
    [No Abstract]   [Full Text] [Related]  

  • 2. Mismanaged measures.
    Nature; 2008 Apr; 452(7187):504. PubMed ID: 18385690
    [No Abstract]   [Full Text] [Related]  

  • 3. The use and abuse of surrogate endpoints in clinical research in transfusion medicine.
    Arnold DM; Lim W
    Transfusion; 2008 Aug; 48(8):1547-9. PubMed ID: 18507746
    [No Abstract]   [Full Text] [Related]  

  • 4. Use and misuse of surrogate outcomes in arrhythmia trials.
    Connolly SJ
    Circulation; 2006 Feb; 113(6):764-6. PubMed ID: 16476858
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials (III). The publication of the results].
    Pascual J; de Pablo I; Gálvez MA; Hernández D
    Nefrologia; 2006; 26(1):25-30. PubMed ID: 16649423
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug markers questioned.
    Ledford H
    Nature; 2008 Apr; 452(7187):510-1. PubMed ID: 18385695
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus on outcome measures for chronic pain trials.
    McQuay H
    Pain; 2005 Jan; 113(1-2):1-2. PubMed ID: 15621355
    [No Abstract]   [Full Text] [Related]  

  • 8. Surrogate end points cloud DES trials.
    Kahn J
    J Interv Cardiol; 2006 Feb; 19(1):117-9. PubMed ID: 16483352
    [No Abstract]   [Full Text] [Related]  

  • 9. Are we ready to use surrogate end points and surrogate tissues to evaluate response to chemopreventive and therapeutic intervention?
    Lotan R
    Clin Cancer Res; 2000 Jun; 6(6):2126-8. PubMed ID: 10873060
    [No Abstract]   [Full Text] [Related]  

  • 10. Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials).
    Choy EH; Mease PJ
    Rheum Dis Clin North Am; 2009 May; 35(2):329-37. PubMed ID: 19647146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inexplicable oversight and a misconception in research.
    Ingenbleek Y; Cynober L
    J Nutr Health Aging; 2005; 9(3):199. PubMed ID: 15864401
    [No Abstract]   [Full Text] [Related]  

  • 12. Surrogate and mediating endpoints: current status and future directions.
    Prentice RL
    J Natl Cancer Inst; 2009 Feb; 101(4):216-7. PubMed ID: 19211455
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of treatment benefits: clinical endpoints relevant to patients.
    Prescrire Int; 2008 Dec; 17(98):260. PubMed ID: 19425279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease.
    Colatsky TJ
    Curr Opin Investig Drugs; 2009 Mar; 10(3):239-44. PubMed ID: 19333881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in Alzheimer's disease: not yet surrogate endpoints.
    Coley N; Andrieu S; Delrieu J; Voisin T; Vellas B
    Ann N Y Acad Sci; 2009 Oct; 1180():119-24. PubMed ID: 19906266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surrogate markers in clinical studies: problems solved or created?
    Manns B; Owen WF; Winkelmayer WC; Devereaux PJ; Tonelli M
    Am J Kidney Dis; 2006 Jul; 48(1):159-66. PubMed ID: 16797400
    [No Abstract]   [Full Text] [Related]  

  • 17. Scales and scores.
    Horwitz NH
    Neurosurgery; 2006 Mar; 58(3):E590. PubMed ID: 16528176
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome measures.
    Essex R
    Ophthalmology; 2008 Jul; 115(7):1269; author reply 1269-70. PubMed ID: 18455237
    [No Abstract]   [Full Text] [Related]  

  • 19. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Farrar JT; Haythornthwaite JA; Jensen MP; Katz NP; Kerns RD; Stucki G; Allen RR; Bellamy N; Carr DB; Chandler J; Cowan P; Dionne R; Galer BS; Hertz S; Jadad AR; Kramer LD; Manning DC; Martin S; McCormick CG; McDermott MP; McGrath P; Quessy S; Rappaport BA; Robbins W; Robinson JP; Rothman M; Royal MA; Simon L; Stauffer JW; Stein W; Tollett J; Wernicke J; Witter J;
    Pain; 2005 Jan; 113(1-2):9-19. PubMed ID: 15621359
    [No Abstract]   [Full Text] [Related]  

  • 20. Scales as outcome measures for Alzheimer's disease.
    Black R; Greenberg B; Ryan JM; Posner H; Seeburger J; Amatniek J; Resnick M; Mohs R; Miller DS; Saumier D; Carrillo MC; Stern Y
    Alzheimers Dement; 2009 Jul; 5(4):324-39. PubMed ID: 19560103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.